Patrick M. Vanderboom

1.9k total citations
31 papers, 938 citations indexed

About

Patrick M. Vanderboom is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, Patrick M. Vanderboom has authored 31 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Infectious Diseases and 6 papers in Physiology. Recurrent topics in Patrick M. Vanderboom's work include SARS-CoV-2 detection and testing (7 papers), Extracellular vesicles in disease (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Patrick M. Vanderboom is often cited by papers focused on SARS-CoV-2 detection and testing (7 papers), Extracellular vesicles in disease (6 papers) and SARS-CoV-2 and COVID-19 Research (5 papers). Patrick M. Vanderboom collaborates with scholars based in United States, India and Japan. Patrick M. Vanderboom's co-authors include Surendra Dasari, K. Sreekumaran Nair, H. Robert Bergen, Elizabeth J. Atkinson, Sundeep Khosla, Thomas A. White, Nathan K. LeBrasseur, Gregory N. Ruegsegger, Katherine A. Klaus and Ian R. Lanza and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cell Metabolism and Diabetes.

In The Last Decade

Patrick M. Vanderboom

30 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick M. Vanderboom United States	17	517	290	124	113	94	31	938
Andrea Dörner Germany	27	827 1.6×	125 0.4×	132 1.1×	104 0.9×	163 1.7×	45	1.6k
Christoph Renné Germany	20	508 1.0×	186 0.6×	73 0.6×	314 2.8×	139 1.5×	29	2.1k
Marina Rode von Essen Denmark	23	374 0.7×	117 0.4×	94 0.8×	48 0.4×	192 2.0×	62	1.9k
Jeffrey A. Canter United States	20	737 1.4×	199 0.7×	165 1.3×	25 0.2×	177 1.9×	27	1.5k
Robert Pick Germany	20	383 0.7×	147 0.5×	39 0.3×	74 0.7×	88 0.9×	30	1.1k
Hefin Jones United Kingdom	9	780 1.5×	146 0.5×	36 0.3×	48 0.4×	83 0.9×	20	1.4k
Sara M. Camp United States	23	769 1.5×	150 0.5×	59 0.5×	190 1.7×	460 4.9×	63	1.8k
Suzhao Li United States	15	490 0.9×	189 0.7×	70 0.6×	100 0.9×	203 2.2×	32	1.4k
Paul E. Zarek United States	9	703 1.4×	105 0.4×	31 0.3×	75 0.7×	141 1.5×	9	2.0k
Eiichi Suematsu Japan	19	630 1.2×	272 0.9×	53 0.4×	118 1.0×	86 0.9×	79	1.3k

Countries citing papers authored by Patrick M. Vanderboom

Since Specialization

Citations

This map shows the geographic impact of Patrick M. Vanderboom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Vanderboom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Vanderboom more than expected).

Fields of papers citing papers by Patrick M. Vanderboom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick M. Vanderboom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Vanderboom. The network helps show where Patrick M. Vanderboom may publish in the future.

Co-authorship network of co-authors of Patrick M. Vanderboom

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick M. Vanderboom. A scholar is included among the top collaborators of Patrick M. Vanderboom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick M. Vanderboom. Patrick M. Vanderboom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Joseph C., Patrick M. Vanderboom, Mindy Kohlhagen, et al.. (2025). B-123 Clinical Implication of Light Chain Fragmentation in Patients with Monoclonal Gammopathies. Clinical Chemistry. 71(Supplement_1). 1 indexed citations

Vanderboom, Patrick M., Yogesh Chawla, Surendra Dasari, et al.. (2024). Differences in the proteome within extracellular vesicles between premalignant and malignant plasma cell disorders. European Journal Of Haematology. 113(3). 351–356. 2 indexed citations

Vanderboom, Patrick M., et al.. (2024). Iron and Copper Liver Concentrations in Wilson Disease. Journal of Gastrointestinal and Liver Diseases. 33(4). 517–523. 1 indexed citations

Vanderboom, Patrick M., et al.. (2023). Detection and quantification of Babesia species intraerythrocytic parasites by flow cytometry. American Journal of Clinical Pathology. 161(5). 451–462. 3 indexed citations

Vanderboom, Patrick M., Linnea M. Baudhuin, Grant M. Spears, et al.. (2023). Lipoprotein (a) cholesterol burden predicts atherosclerotic risk in patients with elevated lipoprotein a. European Journal of Preventive Cardiology. 30(Supplement_1). 1 indexed citations

Vanderboom, Patrick M., et al.. (2023). Hemorrhage Evaluation and Detector System for Underserved Populations: HEADS-UP. SHILAP Revista de lepidopterología. 1(4). 547–556. 4 indexed citations

Renuse, Santosh, Linda M. Benson, Patrick M. Vanderboom, et al.. (2022). 13C15N: glucagon-based novel isotope dilution mass spectrometry method for measurement of glucagon metabolism in humans. Clinical Proteomics. 19(1). 16–16. 4 indexed citations

Vanderboom, Patrick M., Dong‐Gi Mun, Anil K. Madugundu, et al.. (2021). Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx. Molecular & Cellular Proteomics. 20. 100134–100134. 21 indexed citations

Vanderboom, Patrick M., Surendra Dasari, Gregory N. Ruegsegger, et al.. (2021). A size-exclusion-based approach for purifying extracellular vesicles from human plasma. Cell Reports Methods. 1(3). 100055–100055. 50 indexed citations

10.

Nakao, Yasuhiko, Masanori Fukushima, Amy S. Mauer, et al.. (2021). A Comparative Proteomic Analysis of Extracellular Vesicles Associated With Lipotoxicity. Frontiers in Cell and Developmental Biology. 9. 735001–735001. 16 indexed citations

11.

Nakao, Yasuhiko, Pouya Amrollahi, Gopanandan Parthasarathy, et al.. (2021). Circulating extracellular vesicles are a biomarker for NAFLD resolution and response to weight loss surgery. Nanomedicine Nanotechnology Biology and Medicine. 36. 102430–102430. 46 indexed citations

12.

Renuse, Santosh, Patrick M. Vanderboom, Anil K. Madugundu, et al.. (2021). A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens. EBioMedicine. 69. 103465–103465. 43 indexed citations

13.

Mun, Dong‐Gi, Patrick M. Vanderboom, Anil K. Madugundu, et al.. (2021). DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients. Journal of Proteome Research. 20(8). 4165–4175. 23 indexed citations

14.

Javeed, Naureen, Matthew Brown, Patrick M. Vanderboom, et al.. (2021). Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes. Cell Reports. 36(8). 109613–109613. 38 indexed citations

15.

Nasr, Samih H., Surendra Dasari, John C. Lieske, et al.. (2019). Serum levels of DNAJB9 are elevated in fibrillary glomerulonephritis patients. Kidney International. 95(5). 1269–1272. 24 indexed citations

16.

Ruegsegger, Gregory N., Patrick M. Vanderboom, Surendra Dasari, et al.. (2019). Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain. JCI Insight. 4(18). 107 indexed citations

17.

Schafer, Marissa J., Elizabeth J. Atkinson, Patrick M. Vanderboom, et al.. (2016). Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. Cell Metabolism. 23(6). 1207–1215. 162 indexed citations

18.

Graham, Rondell P., Luigi Terracciano, Alexander Meves, et al.. (2016). Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Modern Pathology. 29(6). 607–615. 19 indexed citations

19.

Kohlhagen, Mindy, David R. Barnidge, John R. Mills, et al.. (2016). Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry. Clinical Chemistry. 62(10). 1345–1352. 39 indexed citations

20.

Bergen, H. Robert, Joshua N. Farr, Patrick M. Vanderboom, et al.. (2015). Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay. Skeletal Muscle. 5(1). 21–21. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact